Navigation Links
Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection

'United Kingdom Needs to Wake Up to Threat of Bioterrorism,' Says UK Board

Member General Lord Guthrie

BOSTON, April 22 /PRNewswire/ -- BioDefense Corp., the only company in the world to develop and deploy technology that can neutralize and destroy a biohazardous substance while maintaining the integrity of the tainted materials, today announced it has partnered with General Lord Guthrie, former chief of the British Defense Staff, to establish new security markets for the BioDefense MailDefender(R) in the United Kingdom.

The BioDefense MailDefender system was developed to give organizations increased control over a potentially uncontrollable situation -- the risk of bio-contamination through the mail. This first-of-its kind system decontaminates mail at the point of entry, protecting employees from harm and organizations from the threats of an actual attack or a disruptive hoax.

The MailDefender(R) is currently deployed at the United Nations, U.S. Department of Justice, U.S. Department of Defense, Department of Alcohol, Tobacco and Firearms and several embassies worldwide.

The directors of BioDefense Corp. are hosting an event today to celebrate the partnership between the United States and the United Kingdom. General Lord Guthrie, member of the House of Lords and new member of the BioDefense advisory board, will speak at the company's new Boston world headquarters about the challenges of and solutions to biological threats.

Said BioDefense Executive Vice President Jonathan Morrone: "We are a global company helping countries and corporations worldwide keep their people safe from biological threats, whether the threats originate domestically or internationally. We believe our partnership with General Lord Guthrie and our two countries will further our nations' abilities to defend against bioterrorism, as well as the security hoaxes that often cripple productivity in government agencies and corporate enterprises."

General Charles Ronald Llewelyn Guthrie, Baron Guthrie of Craigiebank, GCB, LVO, OBE, DL became Assistant Chief of the General Staff in 1987 and in 1989 General Officer Commanding 1st British Corps. In 1992 he took command of the British Army of the Rhine and in 1997 became Chief of the General Staff.

Said Lord Guthrie: "The United Kingdom needs to wake up to the threat of bioterrorism, which is far more serious than defense experts realize, and a national strategy to counter bioterrorism needs to be developed."

"A biological attack is likely to be far more devastating than the 9/11 attacks and can cause significantly far more deaths than the number of people who were killed in the Twin Towers attack in New York City," said the Lord Guthrie. He went on to say that, "It is sobering to remember that far more people were killed by Spanish Flu immediately after World War I than hostilities during the war."

Lord Guthrie is an independent member of the House of Lords. He was created a life peer as Baron Guthrie of Craigiebank, of Craigiebank in the City of Dundee, after retiring as Chief of the Defense Staff. He is a director on the board of Colt Defense LLC and Peter Hambro Mining. Lord Guthrie is also the president of several charities, including Action Medical Research, Army Benevolent Fund, Federation of London Youth Clubs and the Progressive Supranuclear Palsy Association.

About BioDefense Corporation

BioDefense Corp. is currently the only company in the world to develop and deploy technology that can neutralize and destroy a biohazardous substance, such as anthrax, ricin and influenza, while maintaining the integrity of mail, packages, currency and medical waste. The process takes about 45 minutes and can be completed in the field or in a small office environment. BioDefense is dedicated to developing advanced technologies and products designed to create safer, healthier home and work environments. BioDefense products and systems help protect people from harmful biological agents and health hazards that are found in many everyday situations. These hazards range from contaminated or infected mail, to microbially contaminated food, to bio-hazardous medical waste and other public health and safety concerns. Visit for more information.

SOURCE BioDefense Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
2. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
3. Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference
4. Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board
5. HHS Secretary Leavitt Announces Members of the National Biodefense Science Board
6. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
7. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
8. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
9. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
10. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
11. BioMagnetics Diagnostics Corp. Rated Speculative Buy, Target Price $1.42 by Beacon Equity Research
Post Your Comments:
(Date:11/24/2015)... Switzerland (PRWEB) , ... November 24, 2015 , ... ... plant and the environment are paramount. Insertion points for in-line sensors can represent ... has developed the InTrac 781/784 series of retractable sensor housings , which ...
(Date:11/24/2015)... , Nov. 24, 2015 HemoShear ... on discovering drugs for metabolic disorders, announced today ... to its Board of Directors (BOD). Mr. Watkins ... of Human Genome Sciences (HGS), and also served ... Jim Powers , Chairman and CEO ...
(Date:11/23/2015)... , Nov. 24, 2015 Women with a ... CT exams face a higher risk of lung cancer than ... presented next week at the annual meeting of the Radiological ... --> --> Lung nodules ... classified as solid or subsolid based on their appearance on ...
(Date:11/23/2015)... The royalty-free a greement a llows ... 112 low- and m iddle-i ncome ... --> The Medicines Patent Pool (MPP) today announced its ... with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that ... virus.  The royalty-free licence will enable generic manufacture of daclatasvir ...
Breaking Biology Technology:
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific discoveries ... doctors and other healthcare providers face challenges in better ... and patients. In addition, as more children continue to ... patient,s adulthood and old age. John M. ... Children,s Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
Breaking Biology News(10 mins):